Literature DB >> 19152347

Factors associated with cancer distress in the Asbestos Post-Exposure Survey (APEXS).

Marion Maurel1, Audrey Stoufflet, Laetitia Thorel, Veronique Berna, Antoine Gislard, Marc Letourneux, Jean-Claude Pairon, Christophe Paris.   

Abstract

OBJECTIVES: CT-scan screening programs for lung cancer detection have been proposed in high-risk subjects, and more recently in former asbestos-exposed subjects. However, to date no data are available on psychological impact of such programs. The aim of this study is to examine the risk factors of psychological distress at baseline of a CT-scan screening program among asbestos-exposed subjects.
METHODS: The Asbestos Post-Exposure Survey (APEXS) was carried out in France between October 2003 and December 2005 in order to screen asbestos-related diseases by CT-scan. Volunteers underwent self-administered questionnaires including an asbestos exposure assessment and, for a large sub-sample, a validated psychological distress scale. Non-exposed subjects were used as reference group.
RESULTS: At baseline, a significant higher level of distress was observed in exposed subjects (n = 3,122) relative to the reference group (n = 486) after adjustment on age, sex, and tobacco status. This distress is associated independently with the self-perception of (i) intensity of asbestos exposure and (ii) the risk of current or future disease related to the asbestos exposure. The perception of the cancer risk related to asbestos seems to play a fundamental role in this psychological distress.
CONCLUSION: In this study, asbestos-exposed subjects experienced a higher significant cancer distress than previously described in literature. These findings may be of potential public health importance. First, the impact of such occupational exposures on quality of life of patients who suffer from cancer related to these exposures has to be appraised. Secondly, the assessment of psychological impact of CT-scan screening programs among asbestos-exposed subjects is also required.

Entities:  

Mesh:

Year:  2009        PMID: 19152347     DOI: 10.1002/ajim.20672

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  7 in total

Review 1.  Role of chest computed tomography in prevention of occupational respiratory disease: review of recent literature.

Authors:  David N Weissman
Journal:  Semin Respir Crit Care Med       Date:  2015-05-29       Impact factor: 3.119

2.  Effects of patient-provider race concordance and smoking status on lung cancer risk perception accuracy among African-Americans.

Authors:  Susan Persky; Kimberly A Kaphingst; Vincent C Allen; Ibrahim Senay
Journal:  Ann Behav Med       Date:  2013-06

3.  CT scan screening is associated with increased distress among subjects of the APExS.

Authors:  Christophe Paris; Marion Maurel; Amandine Luc; Audrey Stoufflet; Jean-Claude Pairon; Marc Letourneux
Journal:  BMC Public Health       Date:  2010-10-26       Impact factor: 3.295

4.  The mental health of asbestos-exposed subjects with pleural abnormalities.

Authors:  Peter Franklin; Monique Robinson; Patrick Abaogye-Sarfo; Latha Samuel; Nola Olsen; Rob Mina; A W Musk; Alison Reid
Journal:  Int Arch Occup Environ Health       Date:  2014-07-24       Impact factor: 3.015

5.  Communicating risks after exposure has ended: former workers' perspectives on PCBs.

Authors:  Kaori Fujishiro; Amy Mobley; Everett Lehman
Journal:  New Solut       Date:  2013-01-01

6.  Alterations in psychosocial health of people affected by asbestos poisoning.

Authors:  Miguel Clemente; Adela Reig-Botella; Juan Carlos Prados
Journal:  Rev Saude Publica       Date:  2015       Impact factor: 2.106

7.  Are the knowledge of non-malignant asbestos-related diseases and lung function impairment differentially associated with psychological well-being? A cross-sectional study in formerly asbestos-exposed workers in Germany.

Authors:  Jessica Lang; Michael K Felten; Thomas Kraus
Journal:  BMJ Open       Date:  2019-10-28       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.